Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

C630028N24Rik Activators

C630028N24Rik Activators encompass a diverse array of chemical compounds that indirectly amplify the functional activity of C630028N24Rik through modulation of various signaling pathways. Forskolin works by raising cAMP levels, thus stimulating PKA, which could phosphorylate proteins within the associated pathways, leading to enhanced C630028N24Rik activity. Meanwhile, PMA, as a potent activator of PKC, and EGCG, as a kinase inhibitor, may modulate respective signaling pathways and indirectly increase the functional activity of C630028N24Rik. The lipid signaling molecule sphingosine-1-phosphate and the SERCA pump inhibitor thapsigargin could elevate the activity of C630028N24Rik by engaging in lipid and calcium signaling pathways. PI3K inhibitors like LY294002 and Wortmannin potentially augment C630028N24Rik activity by diminishing PI3K/Akt signaling and, thus, indirectly promoting pathways where C630028N24Rik is active.

Moreover, SB203580 and U0126, which inhibit p38 MAPK and MEK1/2 respectively, might redirect cellular signaling to favor C630028N24Rik activation by attenuating competitive pathways. The action of calcium ionophore A23187, which increases intracellular calcium levels, could lead to the activation of calcium-dependent signaling pathways, thus enhancing the activity of C630028N24Rik.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a strong activator of protein kinase C (PKC), which can modulate signaling pathways downstream or within the same network as C630028N24Rik, thus potentially increasing its activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG acts as a kinase inhibitor, potentially reducing competitive signaling pathways and indirectly enhancing pathways where C630028N24Rik is functionally active.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can lead to downstream signaling effects that include the activation of pathways in which C630028N24Rik operates, resulting in its enhanced activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which can activate calcium-dependent pathways and indirectly enhance the activity of C630028N24Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which by reducing PI3K/Akt signaling, may enhance pathways in which C630028N24Rik is involved, potentially leading to its increased activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can reduce PI3K/Akt signaling, similarly leading to the potential enhancement of C630028N24Rik activity through the alteration of signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

As an inhibitor of p38 MAPK, SB203580 could shift signaling away from p38 MAPK-dependent pathways, thus potentially enhancing alternative pathways that activate C630028N24Rik.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 inhibits MEK1/2 and can thereby reduce ERK pathway signaling, which may indirectly increase the activity of C630028N24Rik by modulating related signaling pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 increases intracellular calcium levels, which can activate calcium-dependent signaling pathways, possibly leading to the enhancement of C630028N24Rik activity.